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Abstract
Aims/hypothesis The aim of this study was to assess the extent
to which insulin resistance and beta cell dysfunction account
for differences in impaired fasting blood glucose (IFBG)
levels in sub-Saharan African individuals living in different
locations in Europe and Africa. We also aimed to identify
determinants associated with insulin resistance and beta cell
dysfunction among this population.
Methods Data from the cross-sectional multicentre Research
on Obesity and Diabetes among African Migrants (RODAM)
study were analysed. Participants included Ghanaian individuals
without diabetes, aged 18–96 years old, who were residing in
Amsterdam (n=1337), Berlin (n=502), London (n=961),
urban Ghana (n=1309) and rural Ghana (n=970). Glucose
and insulin were measured in fasting venous blood samples.
Anthropometrics were assessed during a physical examination.
Questionnaires were used to assess demographics, physical
activity, smoking status, alcohol consumption and energy intake.
Insulin resistance and beta cell function were determined using
homeostatic modelling (HOMA-IR and HOMA-B, respectively).
Logistic regression analysis was used to study the contribution of
HOMA-IR and inverse HOMA-B (beta cell dysfunction)
to geographical differences in IFBG (fasting glucose
5.6–6.9 mmol/l). Multivariate linear regression analysis was
used to identify determinants associated with HOMA-IR and
inverse HOMA-B.
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Results IFBG was more common in individuals residing in
urban Ghana (OR 1.41 [95% CI 1.08, 1.84]), Amsterdam
(OR 3.44 [95% CI 2.69, 4.39]) and London (OR 1.58 [95%
CI 1.20 2.08), but similar in individuals living in Berlin
(OR 1.00 [95% CI 0.70, 1.45]), compared with those in rural
Ghana (reference population). The attributable risk of IFBG
per 1 SD increase in HOMA-IR was 69.3% and in inverse
HOMA-B was 11.1%. After adjustment for HOMA-IR, the
odds for IFBG reduced to 0.96 (95% CI 0.72, 1.27), 2.52
(95%CI 1.94, 3.26) and 1.02 (95% CI 0.78, 1.38) for
individuals in Urban Ghana, Amsterdam and London
compared with rural Ghana, respectively. In contrast, adjust-
ment for inverse HOMA-B had very minor impact on the ORs
of IFBG. In multivariate analyses, BMI (β=0.17 [95% CI
0.11, 0.24]) and waist circumference (β=0.29 [95%CI 0.22,
0.36]) were most strongly associated with higher HOMA-IR,
whereas inverse HOMA-B was most strongly associated with
age (β = 0.20 [95% CI 0.16, 0.23]) and excess alcohol
consumption (β=0.25 [95% CI 0.07, 0.43]).
Conclusions/interpretation Our findings suggest that insulin
resistance, rather than beta cell dysfunction, is more important
in accounting for the geographical differences in IFBG among
sub-Saharan African individuals. We also show that BMI and
waist circumference are important factors in insulin resistance
in this population.
Keywords Beta cell function . Impaired fasting glycaemia .
Insulin resistance . RODAM study . Sub-SaharanAfricans .
Type 2 diabetes
Abbreviations
HOMA-B HOMA-derived beta cell function
IFBG Impaired fasting blood glucose
IGT Impaired glucose tolerance
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Introduction
The burden of type 2 diabetes is globally high, with
sub-Saharan African migrants in Europe being almost three
times more likely to have type 2 diabetes than the European
host population [1]. In the sub-Saharan African region, type 2
diabetes prevalence has been increasing rapidly over recent
decades and is projected to increase most in this region over
all world regions [2].
A combination of genetics and health-related behaviours
are thought to cause type 2 diabetes by contributing to
increased insulin resistance and reduced beta cell function.
These result in impaired fasting blood glucose (IFBG) and,
ultimately, type 2 diabetes [3, 4]. Interestingly, increased
insulin resistance is initially compensated by elevated beta cell
function [5, 6]. However, once insulin resistance increases to a
level where beta cell function can no longer compensate,
IFBG develops [6].
The pathogenesis of type 2 diabetes in sub-Saharan
Africans is still poorly understood [3]. The importance of
insulin resistance and beta cell failure to produce insulin in
the development of IFBG and type 2 diabetes seems to differ
among sub-Saharan African populations compared with
European populations [7–12]. Studies have shown that insulin
resistance is more severe and beta cell insulin production is
elevated in African populations with normal glucose tolerance
compared with European populations [8, 9, 11]. Furthermore,
during the progression of normal glucose tolerance to IFBG
and type 2 diabetes, insulin production has been found to
decrease more rapidly in African populations than in
European populations [10, 11]. However, most of these
studies have been performed in African-Americans [8, 9, 11,
12] (who are more genetically admixed compared with
sub-Saharan African populations) or on a small sample size
[7, 10].
The high burden of type 2 diabetes among African
migrants in Europe, and the steep increase in type 2 diabetes
in urbanising Africa, indicate that environmental exposures,
such as changes in health-related behaviours, and resulting
changes in anthropometrics might play a role in a disruption
of balance between beta cell function and insulin sensitivity in
these individuals [13]. However, data on the role of the
environment in the development of insulin resistance
and beta cell dysfunction among Africans are limited.
Furthermore, there are indications that the determinants
of insulin resistance and beta cell dysfunction at play
among Africans may differ from European populations
[14]. However, it is unclear which determinants (e.g.
sociodemographic factors, anthropometrics or health-
related behaviours) are driving insulin resistance and beta
cell dysfunction in African populations [15].
The Research on Obesity and Diabetes among African
Migrants (RODAM) study found differences in IFBG and
type 2 diabetes prevalence among Ghanaians that were
resident in multiple geographical locations. While type 2
diabetes prevalence was highest among Ghanaians in Berlin
(12.8%), followed by Amsterdam (11.2%), London (9.4%),
urban Ghana (9.3%) and rural Ghana (4.9%), IFBG
prevalence was highest among Ghanaians in Amsterdam
(27.5%), followed by London (14.7%), urban Ghana
(11.9%), Berlin (11.2%) and rural Ghana (11.2%) [16].
The relatively homogenous but geographically distinct
population of the RODAM study offers an important
opportunity to investigate the role of environment and
health-related behaviours in insulin resistance and beta cell
dysfunction among this sub-Saharan African population.
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We therefore used data from the RODAM study as a means
to: (1) assess the contribution of insulin resistance and beta
cell dysfunction to differences in IFBG between sub-Saharan
Africans in different geographical locations; and (2) investi-
gate which sociodemographic, anthropometric and health-
related behaviour determinants contribute to insulin resistance
and beta cell dysfunction among this population.
Methods
Study design and participants
The design of the RODAM study and the sampling strategy
have been described in detail elsewhere [17]. In brief, between
2012 and 2015 Ghanaian adult residents (aged 18–96 years
old) in rural Ghana, urban Ghana, Amsterdam, London and
Berlin were recruited (Fig. 1). Ghanaian origin was defined as
being born in Ghana and having at least one parent born in
Ghana (first generation) or not born in Ghana but having both
parents born in Ghana (second generation). In Ghana,
participants were randomly selected from a list of 30
enumeration areas in the Ashanti Region, based on the 2010
census. In Amsterdam, Ghanaian participants were randomly
drawn from the AmsterdamMunicipal Health Register, which
holds data on country of birth of citizens and their parents. In
London, Ghanaian organizations served as the sampling frame
since there was no population register for migrant groups. In
Berlin, a similar approach to that in London was used,
including member lists of Ghanaian churches and
organizations as the sampling frame. In the European sites,
selected participants were sent study information and a
response card that they could use to opt in via mail.
Overall 6385 participants were recruited. Of those invited
to participate, the participation rate was 76% in rural Ghana,
74% in urban Ghana, 75% in London and 68% in Berlin. In
Amsterdam, a response to the invitation to participate was
received from 67% and, of these, 53% agreed to participate.
Data from participants who had attended their physical
examination at a research location and had at least one attempt
for blood collection were included in the analysis (Fig. 1). For
the current analysis participants with diabetes according to
self-report, documented as using glucose-loweringmedication
or with a fasting glucose ≥7.0 mmol/l were excluded from the
analyses. This was carried out mainly to eliminate treatment
effect. In addition, samples with plasma glucose of
<2.5 mmol/l were assumed to belong to individuals that suffer
from hypoglycaemia, which is a non-steady-state situation, or
reflect an assay problem [18] and were, therefore, excluded
from analyses. Furthermore, those with missing fasting
glucose or insulin measurements and with negative
HOMA-B values were also excluded. In total 5079
participants were included in the overall analysis. After
exclusion of missing and implausible data, such as energy
intake >95th percentile (20,658 kJ/day), 3309 participants
remained for the multivariate analyses. The main analysis,
which assessed the contribution of insulin resistance and beta
cell dysfunction to geographical differences in IFBG, had an
achieved power of 0.99, detecting the reported differences in
odds for IFBG between locations at an α of 0.05.
Ethics committees of the institutions involved in Ghana,
the Netherlands, the UK and Germany approved the study
protocols before data collection commenced in each country.
Written informed consent was obtained from all participants
enrolled in the study.
Measurements
Data collection was standardised for all locations including
equipment, transport procedures, operating procedures and
questionnaires.
Demographics, education and health-related behaviours
The questionnaire for participants’ demographics, educational
level and health-related behaviours [17] was either
administered by interviewer or self-administered. From this
questionnaire, a positive reply to the question ‘Has someone
in your immediate family (your parents, brothers, sisters, or
children) been diagnosed with diabetes?’ was used to
determine family history of diabetes. Smoking was assessed
as a positive reply to the question ‘Do you smoke at all?’. The
Agreed to participate
(rural Ghana n=946, urban
Ghana n=1619, Amsterdam
n=1900, Berlin n=662, London
n=1258, overall n=6385)
Completed physical
examination and blood Type 2 diabetes according to self-
report, documented glucose-
lowering medication use or fasting
glucose ≥7.0 mmol/l (n=541)
No attempt for blood collection or
did not attend physical examination
(n=487)
Without diabetes cases
(n=5357) 
Missing fasting glucose
measurement or fasting glucose
<2.5 mmol/l (n=182) or missing
insulin measurement (n=77)
Samples with missing
biochemical data excluded
(n=5098)
Negative HOMA-B values (n=19)
Included in main analysis
(n=5079)
Included in multivariate analysis
(n=3309)
Missing or implausible data for
BMI (n=14), waist circumference
(n=16), energy intake (n=1319),
alcohol consumption (n=1138),
physical activity (n=846), and/or
smoking (n=395).
Fig. 1 Flow chart of study design and inclusion in analysis
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WHO STEPS questionnaire [19] was used to derive physical
activity in metabolic equivalent (MET) h/week, which
included physical activity at work, while commuting and in
leisure time [20]. Energy intake was assessed by means of a
standardised Food Propensity Questionnaire developed
specifically for Ghanaian populations, based on the
European Food Propensity Questionnaire [21]. It queried the
usual frequency of food intake during the past 12 months.
Alcohol consumption was calculated in units/week, with
500 ml of beer, 250 ml of wine and 80 ml of spirits being
counted a 1 unit of alcohol. Alcohol consumption was
subsequently classified based on the European Society of
Hypertension/European Society of Cardiology (ESH/ESC)
guidelines for the management of arterial hypertension [22]
into ‘no alcohol consumption’, ‘within the guideline’ and
‘exceeding the guideline’.
Anthropometric measurements Participants were asked to
visit a research facility to take part in a physical examination,
which was conducted by a trained research assistant according
to standard operational procedures. During the physical
examination, height, weight and waist circumference were
assessed in light clothing, in duplicate and truncated to one
decimal place. For height and weight measurements, a SECA
217 (SECA, Hamburg, Germany) portable stadiometer and
SECA 877 scale were used, respectively. BMI was calculated
by dividing weight (kg) by squared height (m2). Blood
pressure was measured three times after 5 min of rest, in a
seated position, using the Microlife WatchBP home monitor
(Microlife WatchBP AG, Widnau, Switzerland); the mean of
the last two measurements was used to determine systolic and
diastolic blood pressure. Hypertension was defined according
to the WHO definition i.e. systolic blood pressure of over
140 mmHg and/or diastolic blood pressure of over
90 mmHg, or participants receiving anti-hypertensive medi-
cation for treatment of hypertension [23].
Biochemical analyses Fasting blood samples were drawn at
a research location by trained research assistants according
to standard operating procedures. All blood samples were
processed and divided into aliquots immediately after
collection, and then temporarily stored at −20°C.
Subsequently, samples were transported to the local
research centres and were checked, registered and stored
at −80°C before being shipped to the laboratory at
Charité–University Medicine Berlin (Berlin, Germany)
for determination of biochemical variables.
Insulin concentrations were assessed using the Mercodia
ELISA kit (Mercodia, Uppsala, Sweden). The intra-
assay CV was 3.4% and the inter-assay CV 3.0%. The
lower detection limit of the Mercodia ELISA was 76 pmol/l.
Fasting glucose, total cholesterol, HDL-cholesterol, LDL-
cholesterol and triacylglycerols were determined using the
ABX Pentra 400 chemistry analyser (HORIBA ABX,
Montpellier, France). Extensive quality checks were con-
ducted during the biochemical analysis, including
blinded serial measurements.
Insulin resistance and beta cell function were assessed
using HOMA [24]: HOMA-derived insulin resistance
index (HOMA-IR) and HOMA-derived beta cell function
(HOMA-B). Both of these have been used extensively in
epidemiological studies [18]. The original HOMA
modelling equations were used to calculate HOMA-IR
and HOMA-B [18]. IFBG was defined as a fasting glucose
between 5.6 and 6.9 mmol/l, according to the American
Diabetes Association (ADA) criteria [25], since previous
studies have shown that a substantial proportion of the
population is misclassified when using the 6.1 mmol/l
blood glucose threshold [26, 27].
Data analysis
The interaction between location and sex in relation to
IFBG tested not significant, therefore analyses were
combined for men and women. The characteristics of
participants included in the analysis were expressed as
medians with interquartile ranges, means with corresponding
95% CI or percentages with corresponding 95% CI.
Mann–Whitney U tests were used to compare HOMA-IR and
HOMA-B between locations. The age- and sex-adjusted
association of HOMA-IR and HOMA-B with IFBG was
studied using logistic regression analysis combining all
geographical locations. In these logistic regression analyses,
the inverse of HOMA-Bwas calculated (1/HOMA-B) and both
HOMA-IR and inverse HOMA-B were converted into
standardised z scores in order to make them comparable.
Attributable risk was calculated to gain more insight into the
relative contribution of HOMA-IR vs HOMA-B to IFBG;
attributable risk with corresponding 95% CI was calculated
for IFBG per SD increase in HOMA-IR and inverse
HOMA-B, both adjusted for age and sex. In assessing the
contribution of HOMA-IR and inverse HOMA-B to the
geographical differences in IFBG, logistic regression analysis
was carried out, using rural Ghana as reference category. In
bivariate and multivariate linear regression analyses, the
association between age, sex, family history of diabetes,
anthropometrics, health-related behaviours and geographical
location with HOMA-IR and inverse HOMA-B was studied.
In these linear regression analyses, HOMA-IR and inverse
HOMA-B were first multiplied by 10 and log10 transformed
to account for non-normal distribution before they were
subsequently converted to standardised z scores to make them
comparable. All continuous determinants were also converted
to z scores. All analyses were performed according to a
complete case analysis approach using SPSS version 23 [28]
and R version 3.2.3 [29].
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Results
Characteristics of the study population
Participants in rural Ghana and London were slightly older
than those in urban Ghana, Amsterdam and Berlin (Table 1).
In urban Ghana, relatively more women participated than in
the other locations, while in Berlin more men participated than
in the other locations. Education level differed greatly
between locations. London Ghanaians reported highest
educational attainment, while rural Ghanaians reported the
lowest. Within the European locations, Amsterdam
Ghanaians reported the lowest levels of education. Family
history of diabetes, BMI and waist circumference were all
lowest in rural Ghana and comparable between the other
locations. Compared with rural Ghana, systolic blood
pressure, diastolic blood pressure, and the prevalence of
hypertension were slightly higher in urban Ghana and
considerably higher in the European locations. Total
cholesterol and LDL-cholesterol in urban Ghana were compa-
rable to those in European locations but higher than in rural
Ghana. Triacylglycerols were higher in rural and urban Ghana
than in the European locations, while HDL-cholesterol was
higher in the European locations compared with Ghana. The
highest physical activity levels, according to MET scores in
h/week, were observed in rural Ghana, followed by
Amsterdam, Berlin, urban Ghana and then London. Energy
intake in kJ/day was highest in Berlin and London, followed
by rural Ghana. Energy intake was lowest urban Ghana,
followed by Amsterdam. The highest smoking prevalence
and alcohol consumption were observed in Berlin.
IFBG, HOMA-IR and HOMA-B levels
between geographical locations
The age-standardised prevalence of IFBG was, as expected,
lower in rural Ghana (10.9%) compared with the other
geographical locations, except for Berlin (10.6%) where the
prevalence was similar to rural Ghana (Fig. 2). The IFBG
prevalence was exceptionally high in Amsterdam (26.0%;
Fig. 2). HOMA-IR differed significantly between locations
(Fig. 3a); the highest median was observed in Amsterdam
(1.54), while the lowest was in rural Ghana (0.86). HOMA-
B was significantly lower in rural Ghana (59.7) compared
with all other locations (Fig. 3b), whereas it was significantly
higher in Berlin compared with urban Ghana and Amsterdam.
HOMA-IR and HOMA-B in relation to IFBG
The age- and sex-adjusted OR for IFBG was 3.26 (95% CI
2.89, 3.69) per SD increase in HOMA-IR and 1.13 (95% CI
1.05, 1.21) per SD increase in inverse HOMA-B (Table 2).
The corresponding attributable risk for IFBG was 69.3 (95%
CI 63.3, 74.6) per SD increase in HOMA-IR and 11.1 (95%
CI 4.9, 16.6) per SD increase in inverse HOMA-B (Table 2).
In Table 3, age- and sex-adjusted ORs for IFBG are
presented across the geographical locations, using rural
Ghana as the reference. In addition, we assessed whether these
geographical differences were accounted for by HOMA-IR or
HOMA-B. Age and sex-adjusted ORs for IFBG were higher
in Amsterdam (OR 3.44 [95% CI 2.69, 4.39]), London (OR
1.58 [95%CI 1.20, 2.08]) and urban Ghana (OR 1.41 [95%CI
1.08, 1.84]) compared with rural Ghana. In Berlin the odds for
IFBG (OR 1.00 [95% CI 0.70, 1.45]) were similar to rural
Ghana. While the ORs increased slightly when HOMA-B
was included in the age- and sex-adjustedmodel, the inclusion
of HOMA-IR reduced the ORs for urban Ghana and London
so that they were similar to those for rural Ghana. For
Amsterdam, the inclusion of HOMA-IR in the age- and
sex-adjusted model reduced the odds for IFBG from 3.44
(95% CI 2.69, 4.39) to 2.52 (95% CI 1.94, 3.26).
Determinants of HOMA-IR and HOMA-B
In bivariate linear regression analyses, the geographical
locations were strongly associated with HOMA-IR and
inverse HOMA-B (Table 4). The directions of association
between HOMA-IR and inverse HOMA-B were opposing
for all determinants in the bivariate analyses; while female
sex, family history of diabetes, higher BMI and higher waist
circumference were associated with higher HOMA-IR, these
determinants were associated with lower inverse HOMA-B.
Besides geographical location, following the bivariate
analysis the strongest positive associations with HOMA-IR
were found for BMI (β = 0.45) and waist circumference
(β = 0.43), and with HOMA-B, for excess alcohol
consumption (β=0.36) and smoking (β=0.40); while the β
coefficients for these determinants were reduced in the
multivariate analyses, they remained strongly associated with
the respective outcomes. The β coefficients for each
geographical location in relation to HOMA-IR and
HOMA-B were greatly reduced in the multivariate analysis
because of the inclusion of all other determinants in this
model.
Discussion
The findings from this study demonstrate that, compared with
Ghanaians in rural Ghana, the prevalence and age- and
sex-adjusted odds for IFBG were higher for those in urban
Ghana, Amsterdam and London but were similar between
those in rural Ghana and Berlin. Insulin resistance accounted
for the differences in IFBG between locations of residence,
except for Amsterdam, while beta cell dysfunction did not.
BMI and waist circumference were most strongly associated
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with insulin resistance in Ghanaians. Exceeding the guideline
for alcohol consumption and smoking were the two
determinants that showed the strongest positive associations
with beta cell dysfunction.
It is speculated that the increasing burden of IFBG and type
2 diabetes in African migrants and urbanising Africa might be
driven by environmental exposures that disturb the balance
between beta cell function and insulin sensitivity [3, 13]. To
our knowledge, this is the first study that has looked at
differences in insulin resistance and beta cell function among
a sub-Saharan African population living in different
geographical locations. Previous research by Osei et al
demonstrated greater insulin resistance in African-Americans
compared with Nigerians [30]. Here we found that levels of
insulin resistance varied between Ghanaians living in different
geographical locations, even within Europe. Insulin resistance
accounted for most of the differences in IFBG between
locations. In contrast, after inclusion of inverse HOMA-B in
an age- and sex-adjusted logistic regression model, the odds
for IFBG were increased in multiple geographical locations
compared with rural Ghana. This finding is consistent with a
study in Koreans that found no association between lower
HOMA-B and IFBG [31]. In the current study, the lack of
contribution of HOMA-B to differences in IFBG between
locations and the weak association between HOMA-B and
IFBG may be suggestive of compensation by the beta cells
to overcome the reduced insulin sensitivity that accompanies
this condition. Hence, in IFBG, environmental and associated
health-related behaviour changes seem to impact insulin
resistance more than beta cell dysfunction.
In sub-Saharan Africans, the prediabetes phase (defined as
IFBG in this study) was suggested to be characterised by
insulin resistance rather than failure of insulin secretion; per
SD increase of HOMA-IR the odds for IFBG were 3.26
compared with 1.13 for 1 SD increase in HOMA-B. In the
corresponding calculations of attributable risk for IFBG, we
found that if the entire study population had a HOMA-IR that
was 1 SD higher, there would be between 63% and 75%more
individuals with IFBG. In comparison, if HOMA-B was 1 SD
higher in the entire population, between 5% and 17% more
individuals would have IFBG (Table 2). This is in line with
studies in African-Americans that found more severe insulin
resistance in individuals with normal glucose tolerance or
prediabetes, the latter being defined as IFBG or impaired
glucose tolerance (IGT) [8, 9, 11, 12]. On the other hand,
studies among sub-Saharan Africans with type 2 diabetes have
found variable insulin resistance in these individuals
compared with individuals without type 2 diabetes, but fast
declines in insulin secretion after diagnosis with type 2
diabetes [7, 10]. According to the model by Gibson [13],
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Table 2 Age- and sex-adjusted OR and attributable risk for IFBG per
SD increase in HOMA-IR and inverse HOMA-B
1 SD OR (95% CI) Attributable risk
% (95% CI)
HOMA-IR 1.860 3.26 (2.89, 3.69) 69.3 (63.3, 74.6)
Inverse HOMA-B 0.015 1.13 (1.05, 1.21) 11.1 (4.9, 16.6)
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sub-Saharan Africans in a normal blood glucose state present
an equilibrium characterised by both higher insulin resistance
and higher beta cell function. When insulin resistance
becomes more severe, initially beta cell function compensates
for this change. However, when this beta cell compensation
fails, type 2 diabetes develops. Longitudinal studies are
needed to fully elucidate the progression from normal blood
glucose state to impaired glucose tolerance to type 2 diabetes
among sub-Saharan Africans.
The determinants that contributed to insulin resistance
among Ghanaians included anthropometric indices that were
also identified by Amoah et al in relation to IFBG in a sample
Table 3 OR (95% CI) for IFBG per geographical location, using rural Ghana as reference
Model of adjustment Rural Ghana Urban Ghana Amsterdam Berlin London
Age + sex 1.00 1.41 (1.08, 1.84) 3.44 (2.69, 4.39) 1.00 (0.70, 1.45) 1.58 (1.20, 2.08)
Age + sex +HOMA-IR 1.00 0.96 (0.72, 1.27) 2.52 (1.94, 3.26) 0.83 (0.56, 1.22) 1.02 (0.78, 1.38)
Age + sex + inverse HOMA-B 1.00 1.49 (1.14, 1.95) 3.76 (2.93, 4.82) 1.13 (0.78, 1.64) 1.72 (1.30, 2.27)
Age + sex +HOMA-IR+ inverse HOMA-B 1.00 1.06 (0.79, 1.44) 3.30 (2.51, 4.36) 1.27 (0.84, 1.91) 1.29 (0.94, 1.77)
Table 4 Bivariate and multivariate analyses for associations between standardised sociodemographic, anthropometric and health-related behaviour
determinants with HOMA-IR and inverse HOMA-B (n = 3309)
Determinant HOMA-IR Inverse HOMA-B
Bivariate Multivariate Bivariate Multivariate
Age −0.07 (−0.10, −0.04) −0.11 (−0.14, −0.08) 0.19 (0.16, 0.22) 0.20 (0.16, 0.23)
Sex (female) 0.38 (0.32, 0.43) 0.16 (0.09, 0.23) −0.49 (−0.54, −0.43) −0.35 (−0.42, −0.28)
Family history of diabetes 0.20 ( 0.12, 0.28) 0.12 (0.04, 0.19) −0.14 (−0.22, −0.06) −0.07 (−0.15, 0.02)
Anthropometrics
BMI 0.45 (0.42, 0.47) 0.17 (0.11, 0.24) −0.37 (−0.39, −0.34) −0.17 (−0.24, −0.10)
Waist circumference 0.43 (0.41, 0.46) 0.29 (0.22, 0.36) −0.32 (−0.35, −0.29) −0.19 (−0.26, −0.12)
Health-related behaviours
Energy intake (kJ/day) −0.05 (−0.08, −0.02) −0.03 (−0.06, 0.00) 0.01 (−0.02, 0.04) 0.02 (−0.02, 0.05)
Alcohol consumptiona
No alcohol 0.00 0.00 0.00 0.00
Within guidelines −0.01 (−0.07, 0.05) 0.04 (−0.03, 0.10) 0.04 (−0.02, 0.10) −0.02 (−0.08, 0.05)
Exceeding guideline −0.30 (−0.46, −0.14) −0.07 (−0.24, 0.10) 0.36 (0.20, 0.52) 0.25 (0.07, 0.43)
Physical activityb
Low activity 0.00 0.00 0.00 0.00
Moderate activity −0.15 (−0.24, −0.06) −0.09 (−0.17, 0.00) 0.11 (0.02, 0.20) 0.04 (−0.05, 0.13)
High activity −0.19 (−0.26, −0.12) −0.12 (−0.19, −0.04) 0.17 (0.10, 0.24) 0.07 (−0.00, 0.14)
Smoking −0.44 (−0.61, −0.28) −0.22 (−0.41, −0.03) 0.40 (0.23, 0.57) 0.17 (−0.02, 0.36)
Geographical location
Rural Ghana 0.00 0.00 0.00 0.00
Urban Ghana 0.55 (0.47, 0.63) 0.11 (0.03, 0.19) −0.42 (−0.50, −0.34) −0.01 (−0.09, 0.08)
Amsterdam 0.71 (0.63, 0.79) 0.10 (−0.00, 0.20) −0.39 (−0.47, −0.31) 0.09 (−0.02, 0.20)
Berlin 0.35 (0.24, 0.45) −0.07 (−0.18, 0.04) −0.62 (−0.72, −0.51) −0.30 (−0.41, −0.18)
London 0.50 (0.41, 0.58) 0.05 (−0.08, 0.17) −0.50 (−0.59, −0.41) −0.07 (−0.20, 0.05)
Data are presented as β coefficients (95% CI)
HOMA-IR and inverse HOMA-B are multiplied by 10, log transformed and converted to standardised z scores. All continuous determinants are also
converted to standardised z scores
In bivariate analyses, each determinant was individually included in the model. In multivariate analyses, all determinants were simultaneously included
in the model
a Guideline: ≤1 unit of alcohol per day for women and ≤2 units of alcohol per day for men [22]
b Physical activity were categorised according to MET h/week [41]
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of 36 Ghanaians residing in urban Ghana [32]. Additionally
we found that alcohol consumption exceeding the
recommendations and smoking contributed to more beta cell
dysfunction. The negative associations of beta cell
dysfunction with BMI and waist circumference reinforce the
notion that compensation by beta cells for more severe insulin
resistance might play a role in IFBG. Furthermore, a family
history of diabetes was found to contribute to increased insulin
resistance severity and somewhat less beta cell dysfunction.
This apparent contradiction could again result from an in-
creased compensatory beta cell function among those with
more severe insulin resistance.
Lifestyle interventions, including either physical activity
alone or combined with dietary advice aiming at weight loss,
have been shown to significantly reduce the progression of
IGT to type 2 diabetes [33]. While pharmacological interven-
tion with, for example, metformin also targets insulin resis-
tance, previous studies do not demonstrate it to be more effec-
tive than lifestyle interventions in terms of primary prevention
[33, 34]. The reduction of BMI could be fruitful as a means to
reduce the high burden of IFBG and subsequent type 2 diabe-
tes among urban Africans and African migrants in Europe.
Despite the observed associations of smoking and excessive
alcohol consumption with beta cell dysfunction, public health
interventions may not be worthwhile considering the relative-
ly low prevalence of alcohol consumption and smoking in the
population studied.
We found that insulin resistance accounted for the
differences in IFBG between all geographical locations except
Amsterdam. Among Ghanaians in Amsterdam, the odds for
IFBG remained three times higher compared with rural Ghana
when adjusted for insulin resistance and beta cell function. An
excessively high prevalence of IFBG among Ghanaians in
Amsterdam has been reported previously [35]. In addition, a
very high prevalence of IFBG has also been observed among
the host Dutch population [36]. We found that Ghanaians in
Amsterdam had more severe insulin resistance compared with
all other sites, and lower beta cell function compared with
London, urban Ghana and Berlin (however, the difference in
beta cell function was only significant compared with Berlin).
This may imply that the failure of beta cell function to com-
pensate for the more severe insulin resistance in Ghanaians in
Amsterdam had already set in. In post hoc analyses (data not
shown), waist circumference was the only modifiable risk
factor associated with IFBG in Amsterdam, while in the other
locations waist circumference was not associated with IFBG.
Hence, there is a potential for body fat distribution and,
perhaps, the ratio of subcutaneous:visceral body fat to play a
role in the difference in IFBG prevalence in Ghanaians in
Amsterdam compared with those in other geographical
locations [37]. However, this requires further study.
It is unclear why there was a relatively low prevalence of
IFBG in Berlin compared with other European sites.
Previously, in the same cohort, we found Berlin to have a
marginally higher prevalence of type 2 diabetes compared
with other European sites and Ghana [16]. It is possible that
IFBG progresses more rapidly into type 2 diabetes in this
location than in other sites. Further research is required to
determine the progression from normal glucose to IFBG and
subsequent type 2 diabetes in different geographical contexts.
Strengths and limitations
This was the first study to compare IFBG, HOMA-IR and
HOMA-B in a large sample of relatively homogenous
sub-Saharan Africans, i.e. all stemming from Ghana, resident
in distinct geographical locations, using standardised
approaches. We have confirmed the importance of insulin
resistance as opposed to beta cell dysfunction in sub-Saharan
Africans in general. Additionally, we have shown that insulin
resistance is important in the context of urbanisation and
migration and have studied the contribution of a range of
determinants to this condition. These findings provide a
foundation for future cardiovascular outcome studies, as well
as studies into the progression of IFBG to type 2 diabetes in
sub-Saharan Africans.
The reliance on fasting blood samples in this study only
allowed us to use IFBG as an endpoint for prediabetes; thus
we were not able to investigate the associations between
geographical differences and determinants of IGT. While
IGT and IFBG identify different groups of individuals [4],
both are considered high risk groups for type 2 diabetes [38].
As a study strength, comparisons between geographical
locations were unlikely to be affected by site differences as
the method for fasting glucose determination was standardised
between locations. Additionally, all blood samples were
collected and transported according to the same protocols in
each of the research locations. Biochemical analyses were
performed centrally, in Charité–University Medicine Berlin,
Berlin, Germany, to avoid intra-laboratory bias.
We used the geographical differences as a means to study
the role of insulin resistance and beta cell dysfunction in IFBG
in sub-Saharan Africans. Because of the cross-sectional nature
of the data we cannot make any statements about causality.
However, reverse causality between insulin resistance and
IFBG, as well as between the determinants and insulin
resistance, is not very likely. Nevertheless, longitudinal data
are needed to study the role of environment on insulin resistance
and beta cell dysfunction in the progression from normal glucose
control toward IFBG and, ultimately, type 2 diabetes.
Furthermore, we used self-reported data for the identification
of determinants, such as diet and physical activity. Reporting
bias, such as socially desirable answering, might have influ-
enced assessment of these determinants [39, 40]. Further in-
depth investigations are needed to study the role of these
health-related behaviours in IFBG among sub-SaharanAfricans.
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Conclusions
We found that insulin resistance, rather than beta cell
dysfunction, accounted for geographical differences in the
prevalence of IFBG among Ghanaian migrants and urban
Ghanaians compared with those in rural Ghana. Our results
suggest that among Ghanaians, BMI and waist circumference
play an important role in insulin resistance. This study was a
first step to gain insight into the role of sociodemographic,
anthropometric and health-related behaviour determinants in
the high burden of IFBG and type 2 diabetes among African
migrants in Europe and urban Africa. Longitudinal studies are
needed to confirm our findings and investigate the role of
other determinants in the impact of insulin resistance and beta
cell dysfunction on IFBG among African populations.
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